Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inulin and Streptococcus salivarius for Halitosis
NCT02794766Phase 2Completed
- Sponsor
- Universidade de Passo Fundo
- Start
- Mar 2014
- Primary completion
- May 2015
- Modality
- Live Biotherapeutic Products
01
Overview
Phase 2, randomised, double-blind trial of Streptococcus salivarius and inulin in halitosis, sponsored by Universidade de Passo Fundo. Primary endpoint: Halitosis Measured by Organoleptic Test at 14 days. Started Mar 2014; status: completed.
02
Drugs
Streptococcus salivariusinulin
03
Conditions
halitosis
Beyond the preview
Go deeper on NCT02794766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02794766.